DE:JNY Stock Latest News
Company AnnouncementsJW Therapeutics Announces Proposed Eureka Asset Transfer and Licensing Deal3d ago
Company AnnouncementsJW Therapeutics Narrows Interim Loss as Carteyva Sales Jump and Costs Ease2M ago
Company AnnouncementsJW Therapeutics Sets Board Meeting to Approve Interim 2026 Results3M ago
Company AnnouncementsJW Therapeutics Shareholders Back All AGM Resolutions, Approve Fresh Capital Mandates4M ago
Company AnnouncementsJW Therapeutics Clarifies Board and Committee Structure4M ago
Company AnnouncementsJW Therapeutics Sets 2026 AGM to Approve Results, Board and Share Issuance Mandate5M agoCompany AnnouncementsJW Therapeutics Grants New Equity Awards to Employees Under Post-IPO Schemes6M ago
Company AnnouncementsJW Therapeutics Boosts 2025 Revenue on CAR-T Sales and Licensing but Books Major Pipeline Impairments7M ago
Company AnnouncementsJW Therapeutics Schedules Board Meeting to Approve 2025 Results and Consider Dividend8M ago
Company AnnouncementsJW Therapeutics Grants New Share Options and RSUs to CEO and Key Staff10M ago
Company AnnouncementsJW Therapeutics Outlines Board and Committee Structure10M ago
Company AnnouncementsJW Therapeutics Extends Vector Supply Agreement With Juno to 202810M ago
- Company AnnouncementsJW Therapeutics Reports Promising Results for JWCAR201 in Hematology Study11M ago
- Company AnnouncementsJW Cayman and Regeneron Amend Collaboration for Oncology Product Development1y ago
- Company AnnouncementsJW Therapeutics Advances SLE Treatment with Promising Phase I Results1y ago
Company AnnouncementsJW Therapeutics Advances with In-House Lentiviral Vector for Carteyva®1y ago
Company AnnouncementsJW Therapeutics Delays Circular Dispatch for Incentivization Scheme1y ago